Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-137105
Filing Date
2023-05-05
Accepted
2023-05-05 16:09:58
Documents
16
Period of Report
2023-05-05

Document Format Files

Seq Description Document Type Size
1 6-K d305233d6k.htm 6-K 12537
2 EX-99.1 d305233dex991.htm EX-99.1 32769
3 EX-99.2 d305233dex992.htm EX-99.2 79447
4 EX-99.3 d305233dex993.htm EX-99.3 25364
5 EX-99.4 d305233dex994.htm EX-99.4 36237
6 GRAPHIC g3052331sp22.jpg GRAPHIC 4158
7 GRAPHIC g3052332sp22a.jpg GRAPHIC 3262
8 GRAPHIC g3052333sp22b.jpg GRAPHIC 2671
9 GRAPHIC g3052334sp22c.jpg GRAPHIC 1090
10 GRAPHIC g305233neww.jpg GRAPHIC 870
11 GRAPHIC g305233sp22b.jpg GRAPHIC 2671
12 GRAPHIC g305233sp22d.jpg GRAPHIC 744
13 GRAPHIC g305233sp24aa.jpg GRAPHIC 5417
14 GRAPHIC g305233sp24b.jpg GRAPHIC 6269
15 GRAPHIC g305233sp24bb.jpg GRAPHIC 1411
16 GRAPHIC g305233sp24cc.jpg GRAPHIC 3755
  Complete submission text file 0001193125-23-137105.txt   233568
Mailing Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273
Business Address 9, RUE DE BITBOURG LUXEMBOURG N4 L-1273 354 422-4500
Alvotech (Filer) CIK: 0001898416 (see all company filings)

IRS No.: 981629342 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41421 | Film No.: 23893899
SIC: 2836 Biological Products, (No Diagnostic Substances)